These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21615623)

  • 1. Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome.
    Kanazawa M; Watanabe S; Tana C; Komuro H; Aoki M; Fukudo S
    Neurogastroenterol Motil; 2011 Aug; 23(8):754-e332. PubMed ID: 21615623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serotonin 5- HT4 receptor agonist (mosapride citrate)].
    Odaka T; Suzuki T; Seza A; Yamaguchi T; Saisho H
    Nihon Rinsho; 2006 Aug; 64(8):1491-4. PubMed ID: 16898619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 5-hydroxytryptamine receptor 4 agonist mosapride on human gastric accommodation.
    Amano T; Ariga H; Kurematsu A; Yamato S; Morioka S; Masaka A; Kanazawa M; Fukudo S
    Neurogastroenterol Motil; 2015 Sep; 27(9):1303-9. PubMed ID: 26303048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are symptomatic changes in irritable bowel syndrome correlated with the capsule endoscopy transit time? A pilot study using the 5-HT4 receptor agonist mosapride.
    Nakamura M; Ohmiya N; Miyahara R; Ando T; Watanabe O; Kawashima H; Itoh A; Hirooka Y; Niwa Y; Goto H
    Hepatogastroenterology; 2011; 58(106):453-8. PubMed ID: 21661412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tegaserod on recto-sigmoid tonic and phasic activity in constipation-predominant irritable bowel syndrome.
    Di Stefano M; Miceli E; Mazzocchi S; Tana P; Missanelli A; Corazza GR
    Am J Gastroenterol; 2007 Aug; 102(8):1720-6. PubMed ID: 17521397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.
    Choi CH; Kwon JG; Kim SK; Myung SJ; Park KS; Sohn CI; Rhee PL; Lee KJ; Lee OY; Jung HK; Jee SR; Jeen YT; Choi MG; Choi SC; Huh KC; Park H
    Neurogastroenterol Motil; 2015 May; 27(5):705-16. PubMed ID: 25809913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
    Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DSP-6952, a novel 5-HT
    Mine Y; Itakura T; Oku S; Asada R; Shimizu I
    Eur J Pharmacol; 2018 May; 826():123-132. PubMed ID: 29428470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meal induced rectosigmoid tone modification: a low caloric meal accurately separates functional and organic gastrointestinal disease patients.
    Di Stefano M; Miceli E; Missanelli A; Mazzocchi S; Corazza GR
    Gut; 2006 Oct; 55(10):1409-14. PubMed ID: 16434428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mosapride citrate, a 5-HT4-receptor agonist, on gastric distension-induced visceromotor response in conscious rats.
    Seto Y; Yoshida N; Kaneko H
    J Pharmacol Sci; 2011; 116(1):47-53. PubMed ID: 21521930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients.
    Liu Z; Sakakibara R; Odaka T; Uchiyama T; Uchiyama T; Yamamoto T; Ito T; Asahina M; Yamaguchi K; Yamaguchi T; Hattori T
    Mov Disord; 2005 Jun; 20(6):680-6. PubMed ID: 15719424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of mosapride citrate on proximal and distal colonic motor function in the guinea-pig in vitro.
    Kim HS; Choi EJ; Park H
    Neurogastroenterol Motil; 2008 Feb; 20(2):169-76. PubMed ID: 17931343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mosapride citrate, a 5-HT₄ receptor agonist, increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men.
    Aoki K; Kamiyama H; Masuda K; Togashi Y; Terauchi Y
    Endocr J; 2013; 60(4):493-9. PubMed ID: 23257734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of phloroglucinol on rectosigmoid motility stimulated by a test meal. Study in patients with irritable bowel syndrome].
    Cargill G; Salin B; Lubin S; Kohler F; Coste T; Rautureau J
    Presse Med; 1992 Jan 4-11; 21(1):19-23. PubMed ID: 1531259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of DA-6886, a novel 5-HT4 receptor agonist to accelerate colonic motor activity in mice.
    Lee MJ; Cho KH; Park HM; Sung HJ; Choi S; Im W
    Eur J Pharmacol; 2014 Jul; 735():115-22. PubMed ID: 24769304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mosapride on esophageal secondary peristalsis in humans.
    Chen CL; Liu TT; Yi CH; Orr WC
    Neurogastroenterol Motil; 2011 Jul; 23(7):606-e249. PubMed ID: 21501334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics).
    Khalif IL; Quigley EM; Makarchuk PA; Golovenko OV; Podmarenkova LF; Dzhanayev YA
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):17-22. PubMed ID: 19337628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT4 receptor agonist mosapride attenuates inflammation of reflux esophagitis.
    Zhuang ZH; Zou FM; Tang DP; Zhuang JY; Wei JJ; Yang LY
    Hepatogastroenterology; 2014; 61(129):115-9. PubMed ID: 24895805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mosapride on recovery of intestinal motility after hand-assisted laparoscopic colectomy for carcinoma.
    Narita K; Tsunoda A; Takenaka K; Watanabe M; Nakao K; Kusano M
    Dis Colon Rectum; 2008 Nov; 51(11):1692-5. PubMed ID: 18584249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.